Clearpoint Neuro Inc reports results for the quarter ended in December - Earnings Summary

Clearpoint Neuro

02/03/2022 07:43

* Clearpoint Neuro Inc  CLPT.OQ  reported a quarterly
adjusted
loss of 20 cents​​ per share for the quarter ended in December.
The lone analyst forecast for the quarter was for a loss of 19
cents per share.
    * Revenue rose 15.2% to $4.28 million from a year ago; 
analysts
expected $4.30 million. 
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Clearpoint Neuro Inc shares had fallen by 23.9% this
quarter.
    * Wall Street's median 12-month price target for Clearpoint
Neuro
Inc is $32.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated March 2 at 07:43 a.m.  ​All
figures in US dollars unless otherwise stated